BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


June Archive 2003 - have your press release here?

CURACYTE RECEIVES FDA CLEARANCE FOR CLINICAL TRIAL OF PHP AS AN ADJUNCT TO IL-2 CANCER THERAPY

BiotechTracker - Biogen and IDEC Underwhelm 

BiotechTracker - Copaxone Benefits Patients Who Fail Avonex

BiotechTracker - Another TNF Inhibitor Shows Promise

BiotechTracker - Exanta Continues to Impress

BioTech Stock Report today announced the release of its July 2003 issue

Biotech Tracker - Expanded Arixtra Label Approved 

Tm BIOSCIENCE LAUNCHES DRUG METABOLISM GENETIC TEST

Tm BIOSCIENCE CLOSES $5.1 MILLION PRIVATE PLACEMENT

Haptogen New anti-infectives in final pre-clinical phase

Haptogen sign deal to access new display technology

Nonlinear Dynamics employs Western Regional Sales Manager

University of Cambridge grants exclusive worldwide licence to Paradigm Therapeutics to exploit exciting new drug target for the treatment of chronic pain

Syngene - New Dedicated System for Chemiluminescent Imaging

BiotechTracker - Long-Term Data Still Lacking for Inhaled Insulin Formulations 

BiotechTracker - La Jolla Pharmaceutical Presses Forward with Riquent  

BiotechTracker - Xyotax Receives Fast Track Status 

Agilent Technologies and Dharmacon to Use Microarrays to Analyze Cellular Effects of RNAi Gene Silencing for Drug Discovery Research

Oxford BioMedica -  Interview with UK's Leading Gene Therapy Company for Comment on Genetics White Paper

Agilent Technologies Introduces Microarray Data Extraction Software Compatible with Any 1" x 3" Glass Slide Microarray

Oxford BioMedica presents manufacturing process for gene therapy, ProSavin during BIO 2003

Synbiosis New Automated Colony Counters

European Biotechnology Crossroads presents international conference programme

Argenta Discovery announces results for the year ended 31

Biotech Stock Report - They Just Don’t Want to Quit

NORTHERN IRELAND DIAGNOSTICS COMPANY INVESTS £123M IN LEADING-EDGE BIOTECHNOLOGY

CURACYTE SCIENTISTS DISCOVER NEW ANTI-TUMOR AGENTS

atugen extends agreement with Schering AG, includes RNA interference technology

BiotechTracker - Expanded Cerezyme Label Likely in Europe

BiotechTracker - Study Supports Arixtra Label Expansion 

CORDIA 2003 EuropaBio and Partners announce preview programme for Europe’s first International biotech convention

BiotechTracker - Isis and Eli Lilly Unwind Affinitak Collaboration 

BiotechTracker - Cystic Fibrosis Gene Therapy Moves Forward 

Syngene USA Opens New Headquarters

QualityMetric Clinical Trials Consulting Team:

PerkinElmer and Nonlinear Dynamics sign new OEM distribution agreement for leading proteomics software solution

ImmBio raises €1million to finance respiratory disease vaccine development

BiotechTracker - ASCO Data Support Bexxar Approval

BiotechTracker - 63-Week Analysis Demonstrates Rebif Advantages Over Avonex 

BiotechTracker - Profile of Tularik 

BiotechTracker - Point Therapeutics Steps Up to the Challenge of Pan-Stimulation of Blood Cells 

Biotech Stock Report - WOW!

Chiracon GmbH joins exclusive circle of Startup-Partners

Ocimum Biosolutions launches gene optimization software, OptGeneTM

Synexus announces big increase in turnover and move into profitability

Syncroscopy New Application of Microscopy Software Helps Determine Man’s Evolutionary Progress with Greater Certainty

ChemOvation and Cancer Research Technology have entered into a collaborative agreement in the field of target validation drug discovery

BiotechTracker - ReoPro for Stroke 

Schroder Ventures Life Sciences fund raises over US $400 million for Third International Life Sciences Fund

BiotechTracker - Generex To Initiate Phase IIb Oral Insulin Trials 

Biotech Stock Report - The BioCycle

Biotech Stock Report - outlook on multiple myeloma therapeutics

GATC and GENOVAC co-operate in the Field of Antibody Production

Urch launches comprehensive report on Manufacturing in the Global Pharmaceuticals Industry 

BSI TACKLES MEMBRANE PROTEIN BOTTLENECK

Zetia: Potential to reshape the cholesterol drug landscape?

Multiple Myeloma: Increasing the therapeutic options

November 2003 Archive

October 2003 Archive

September 2003 Archive

July/August 2003 Archive

June 2003 Archive

May 2003 Archive

March/April 2003 Archive

February 2003 Archive

January 2003 Archive

December Archive

November Archive

October Archive

September Archive

August Archive

July Archive

June Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.